Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
Authors
Keywords
T cells, Cytotoxic T cells, Cytokines, Memory T cells, Flow cytometry, Cell staining, Gene expression, Multiple sclerosis
Journal
PLoS One
Volume 7, Issue 11, Pages e47578
Publisher
Public Library of Science (PLoS)
Online
2012-12-01
DOI
10.1371/journal.pone.0047578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells
- (2014) D. B. Rosen et al. JOURNAL OF IMMUNOLOGY
- Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis
- (2012) Finn Sellebjerg et al. PLoS One
- CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
- (2011) Viviana Annibali et al. BRAIN
- Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism
- (2011) Jaime Ramos-Cejudo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
- (2011) Mario Skarica et al. JOURNAL OF NEUROIMMUNOLOGY
- Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
- (2011) M. Mehling et al. NEUROLOGY
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
- (2010) Michael Croft Annual Review of Immunology
- CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC
- (2010) Laura Maggi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment
- (2010) Giovanni Frisullo et al. Multiple Sclerosis Journal
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
- (2009) M. Khademi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
- (2009) P. Kivisakk et al. NEUROLOGY
- Induction of systemic TNFα in Natalizumab-treated multiple sclerosis
- (2008) M. Khademi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Differential expression of CD26 on virus-specific CD8+T cells during active, latent and resolved infection
- (2008) Chris C. Ibegbu et al. IMMUNOLOGY
- Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells
- (2008) Max-Philipp Stenner et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started